The legal action, spearheaded by the firm Faruqi & Faruqi, LLP, alleges that Calix executives failed to disclose that the company’s first-quarter margins were artificially propped up by an expiring stockpile of memory components. According to the complaint, management omitted the fact that this supply was dwindling, leaving the business vulnerable to rising market prices. The discrepancy came to light on April 21, 2026, when the company reported a sequential decline in non-GAAP gross margins and provided lower-than-anticipated guidance. During the subsequent earnings call, the CFO confirmed that the advantage of previous advance purchasing had vanished, forcing the company to procure components at current market rates. Following the disclosure, Calix shares dropped 13.98%, closing at $42.65 per share on April 22, 2026. Investors who suffered losses during the specified period are encouraged to contact partner James (Josh) Wilson to review their legal options. While the court will appoint a lead plaintiff to represent the class, those who choose not to seek the role remain eligible to participate in any potential recovery without taking further action.
Calix Investors Face July Deadline in Securities Class Action
Investors who purchased Calix stock between January 28 and April 21, 2026, have until July 27 to seek lead plaintiff status in a federal class action lawsuit. The litigation centers on claims that the company misled shareholders regarding the sustainability of its profit margins amid fluctuating memory component costs.





Comments (0)
No comments yet. Be the first!